These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2. Blechacz BR; Smoot RL; Bronk SF; Werneburg NW; Sirica AE; Gores GJ Hepatology; 2009 Dec; 50(6):1861-70. PubMed ID: 19821497 [TBL] [Abstract][Full Text] [Related]
9. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines. Riantana H; Waenphimai O; Mahalapbutr P; Karnchanapandh K; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K Pathol Res Pract; 2023 Aug; 248():154678. PubMed ID: 37454493 [TBL] [Abstract][Full Text] [Related]
10. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain. Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992 [TBL] [Abstract][Full Text] [Related]
11. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells. Jinawath A; Akiyama Y; Sripa B; Yuasa Y J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219 [TBL] [Abstract][Full Text] [Related]
13. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma. Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637 [TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells. Ustundag Y; Bronk SF; Gores GJ World J Gastroenterol; 2007 Feb; 13(6):851-7. PubMed ID: 17352013 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
17. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma. Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630 [TBL] [Abstract][Full Text] [Related]
19. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment. Zhou Y; Xu L; Wang Z; Liu H; Zhang X; Shu C; Zhang M; Wang T; Xu X; Pu X; He J; Wang P; Qiu Y; Xu G; Zou X; Zhu Y; Wang L Theranostics; 2022; 12(8):3911-3927. PubMed ID: 35664077 [No Abstract] [Full Text] [Related]
20. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]